Laurion Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-25,600
Closed -$2.31M 980
2019
Q3
$2.31M Sell
25,600
-55,300
-68% -$6.3M 0.02% 474
2019
Q2
$9.55M Sell
80,900
-14,600
-15% -$1.47M 0.09% 192
2019
Q1
$8.27M Buy
95,500
+56,200
+143% +$4.78M 0.11% 144
2018
Q4
$2.48M Buy
+39,300
New +$2.7M 0.04% 412

Other funds holding EXAS

Laurion Capital Management's EXAS Position: Q1 2026 in Review

Laurion Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 499,532 shares — an estimated $50.7M sold.

Laurion Capital Management first reported a position in EXAS in Q3 2014 and held it in 6 quarters. The position peaked at $50.7M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Laurion Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Laurion Capital Management sold 499,532 Exact Sciences shares in Q1 2026, an estimated $50.7M.
  • Laurion Capital Management first reported a position in Exact Sciences in Q3 2014 and held it in 6 quarters.
  • Laurion Capital Management's Exact Sciences position peaked at $50.7M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.